Susquehanna International Group
COGT icon

Susquehanna International Group’s Cogent Biosciences COGT Stock Holding History

Susquehanna International Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Sell
70,478
-213,019
-75% -$7.87M ﹤0.01% 5486
2025
Q4 		$10.1M Buy
283,497
+204,874
+261% +$5.76M ﹤0.01% 3030
2025
Q3 		$1.13M Sell
78,623
-327,495
-81% -$3.88M ﹤0.01% 7053
2025
Q2 		$2.92M Buy
406,118
+269,376
+197% +$1.49M ﹤0.01% 5017
2025
Q1 		$819K Sell
136,742
-14,876
-10% -$117K ﹤0.01% 7766
2024
Q4 		$1.18M Buy
151,618
+108,248
+250% +$1.08M ﹤0.01% 6543
2024
Q3 		$468K Sell
43,370
-59,830
-58% -$583K ﹤0.01% 8610
2024
Q2 		$870K Buy
103,200
+10,267
+11% +$77.9K ﹤0.01% 6914
2024
Q1 		$625K Buy
92,933
+5,185
+6% +$32.1K ﹤0.01% 7975
2023
Q4 		$516K Buy
87,748
+55,520
+172% +$425K ﹤0.01% 8596
2023
Q3 		$314K Buy
32,228
+11,593
+56% +$137K ﹤0.01% 9244
2023
Q2 		$244K Sell
20,635
-95,175
-82% -$1.09M ﹤0.01% 9851
2023
Q1 		$1.25M Buy
115,810
+84,766
+273% +$1.08M ﹤0.01% 6244
2022
Q4 		$359K Sell
31,044
-44,458
-59% -$551K ﹤0.01% 8666
2022
Q3 		$1.13M Buy
75,502
+40,157
+114% +$550K ﹤0.01% 6321
2022
Q2 		$319K Buy
+35,345
New +$241K ﹤0.01% 9416
2021
Q2 		– Sell
-284,250
Closed -$2.5M – 12615
2021
Q1 		$2.5M Buy
+284,250
New +$2.74M ﹤0.01% 5381
2019
Q3 		– Sell
-5,926
Closed -$62K – 10225
2019
Q2 		$62K Buy
+5,926
New +$78.9K ﹤0.01% 9786
2018
Q4 		– Sell
-7,699
Closed -$317K – 9037
2018
Q3 		$317K Buy
+7,699
New +$434K ﹤0.01% 7379

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Susquehanna International Group's COGT Position: Q1 2026 in Review

Susquehanna International Group reduced its Cogent Biosciences (COGT) stake by 75% in Q1 2026, selling an estimated $7.87M and leaving 70,478 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #5486.

Susquehanna International Group first reported a position in COGT in Q3 2018 and has held it in 19 quarters since. The position peaked at $10.1M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Susquehanna International Group held 70,478 shares of Cogent Biosciences worth $2.71M as of Q1 2026.
  • Susquehanna International Group sold 213,019 Cogent Biosciences shares in Q1 2026, an estimated $7.87M.
  • Cogent Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5486 holding.
  • Susquehanna International Group first reported a position in Cogent Biosciences in Q3 2018 and has held it in 19 quarters since.
  • Susquehanna International Group's Cogent Biosciences position peaked at $10.1M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.